EMD-28255

Single-particle
2.2 Å
EMD-28255 Deposition: 28/09/2022
Map released: 31/05/2023
Last modified: 19/07/2023
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-28255

70S map for: "Atomistic simulations of the E. coli ribosome provide selection criteria for translationally active substrates"

EMD-28255

Single-particle
2.2 Å
EMD-28255 Deposition: 28/09/2022
Map released: 31/05/2023
Last modified: 19/07/2023
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Escherichia coli
Sample: 70S ribosome complex with mRNA, A- and P-site Met-NH-tRNAs

Deposition Authors: Watson ZL , Cate JHD
Atomistic simulations of the Escherichia coli ribosome provide selection criteria for translationally active substrates.
Watson ZL , Knudson IJ, Ward FR , Miller SJ , Cate JHD , Schepartz A , Abramyan AM
(2023) Nat Chem , 15 , 913 - 921
PUBMED: 37308707
DOI: doi:10.1038/s41557-023-01226-w
ISSN: 1755-4349
Abstract:
As genetic code expansion advances beyond L-α-amino acids to backbone modifications and new polymerization chemistries, delineating what substrates the ribosome can accommodate remains a challenge. The Escherichia coli ribosome tolerates non-L-α-amino acids in vitro, but few structural insights that explain how are available, and the boundary conditions for efficient bond formation are so far unknown. Here we determine a high-resolution cryogenic electron microscopy structure of the E. coli ribosome containing α-amino acid monomers and use metadynamics simulations to define energy surface minima and understand incorporation efficiencies. Reactive monomers across diverse structural classes favour a conformational space where the aminoacyl-tRNA nucleophile is <4 Å from the peptidyl-tRNA carbonyl with a Bürgi-Dunitz angle of 76-115°. Monomers with free energy minima that fall outside this conformational space do not react efficiently. This insight should accelerate the in vivo and in vitro ribosomal synthesis of sequence-defined, non-peptide heterooligomers.